QUALTEX UK LIMITED

Company number 00708974 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Score: B+

Explanation: Qualtex UK Limited is a mature, fundamentally robust business showing signs of a strong underlying constitution. However, it is currently experiencing acute, non-recurring "infections"—specifically foreign exchange losses, bad debts, and investment impairments—that have temporarily suppressed its net vitality. The recent renewal of a £3 million credit facility acts as a strong immune booster, ensuring short-term stability despite a significant dividend payout that exceeds current year profits.


1. Key Vital Signs

  • Revenue (The Pulse): £24.3 million (down from £26m in 2023). The patient's pulse remains strong, though slightly slower than the previous year. This deceleration is attributed to a sluggish e-commerce environment rather than a systemic failure of the business model.
  • Gross Profit Margin (Blood Pressure): 20.9% (up from 19.9%). This is a highly positive vital sign. It indicates that the core "circulatory system"—selling appliance parts—is healthy, with trade sales effectively compensating for the e-commerce slowdown.
  • Operating Profit Margin (Cholesterol Levels): 5.7% (down from 7.3%). The arteries are showing some narrowing. While the gross margin improved, exceptional costs have built up, restricting the flow of operating profit.
  • Profit Before Tax (Organ Function): £1.2 million (down from £1.68 million). Organ function is impaired compared to 2023, primarily due to external shocks rather than core operational decay.
  • Dividend Payout (Blood Loss): £1.83 million. The business distributed significantly more cash to its shareholders than it generated in net profit (£878k) this year. While likely funded by healthy retained earnings from prior years, this represents a significant cash extraction.

2. Symptoms Analysis

The drop in the bottom line is not a symptom of a failing core business, but rather the result of three distinct "pathogens" attacking the system:

  1. Foreign Exchange & Bad Debt Shock (£101k cost vs. £244k income in 2023): The company has caught a mild external bug. Currency fluctuations and customers defaulting have reversed a previous financial gain into a loss.
  2. Investment Impairment (£102k): The write-down of the investment in JEGS Electrical Limited represents a localized infection that required surgical removal from the asset register.
  3. E-commerce Slowdown: While trade sales are healthy, the broader e-commerce sector is experiencing a temporary "malaise," dampening overall top-line growth.

3. Diagnosis

Condition: Acute Market Exhaustion with Underlying Robust Health

Qualtex UK Limited is a healthy, long-standing patient (incorporated in 1961) that has suffered a bout of short-term fatigue. The core business—wholesale of home appliance spare parts—is defensively positioned; people always need to fix white goods, especially in tough economic climates.

The improvement in gross margin is the most telling diagnostic indicator: it proves the company has strong pricing power and a well-managed supply chain. The drop in net profit is entirely explained by exceptional items (FX, bad debt, and impairment) rather than a loss of competitive edge.

The primary area of concern is the dividend distribution. Paying out £1.83 million in dividends against a net profit of £878k means the business is consuming its own financial reserves (retained earnings) to reward its owners (the Hulme family and Qualtex Global). While the balance sheet is described as "robust" and can easily handle this, repeated over-distribution without replacing the "blood" through retained profits could eventually lead to anemia (undercapitalization).


4. Recommendations

To maintain long-term financial wellness and build resilience against future market illnesses, the following preventative care regimen is recommended:

  1. Vaccinate Against FX Volatility: The swing from a £244k FX gain to a £101k FX loss highlights significant currency exposure. The company should review its hedging strategies to immunize itself against currency fluctuations, ensuring exchange rate movements don't continue to erode the gross margin improvements achieved by the operations team.
  2. Strengthen the Credit Immune System: The bad debt cost indicates that some customers are failing to pay. Implement stricter credit control checks and consider credit insurance to isolate the business from the risk of customer insolvency.
  3. Monitor the Investment Portfolio: The £102k impairment of JEGS Electrical Limited needs ongoing observation. Ensure this is a one-off write-down and not the beginning of a chronic decline in the value of subsidiary investments.
  4. Moderate the Dividend "Bleed": While the company can currently sustain dividend payouts exceeding net profit, this practice reduces the financial cushion available for downturns. Future dividends should ideally be aligned with net profit generation to preserve working capital and strengthen the balance sheet against future shocks.
  5. Leverage the Financial Safety Net: The £3 million revolving credit facility renewed until 2028 is an excellent financial vitamin. Ensure this facility is used strategically—to fund stock purchases at optimal times or to invest in operational efficiency—rather than merely supporting cash flow during heavy dividend extraction.

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 10 August 2026